Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended dual antiplatelet therapy after DES vs BMS PCI
2009-015712-17Phase 4Completed
- Sponsor
- Baim Institute for Clinical Research
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clopidogrel and prasugrel in coronary arteriosclerosis (2 arms), sponsored by Baim Institute for Clinical Research. Primary endpoints: Major adverse cardiac and cerebrovascular events (MACCE) and Stent thrombosis (ARC definite or probable). Started Feb 2010; status: completed.
02
Drugs
clopidogrelprasugrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2009-015712-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015712-17.